Atosiban vs ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan

Autor: M. Miranda, Giovanni Nazzaro, M. L. Pisaturo, G. De Placido, A. Merenda, Mariavittoria Locci, P. Laviscio, R. Poppiti, A. Stile
Přispěvatelé: Locci, M., Nazzaro, G., Merenda, A., Pisaturo, M., Laviscio, P., Poppiti, R., Miranda, M., Stile, A., De Placido, G., Locci, Mariavittoria, Nazzaro, G, Merenda, A, Pisaturo, Ml, Laviscio, P, Poppiti, R, Miranda, M, Stile, A, DE PLACIDO, Giuseppe
Rok vydání: 2006
Předmět:
Zdroj: Journal of Obstetrics and Gynaecology. 26:396-401
ISSN: 1364-6893
0144-3615
DOI: 10.1080/01443610600719883
Popis: Our objective was to compare the effectiveness and safety of atosiban and ritodrine, in pregnancies obtained by intracytoplasmic sperm injection (ICSI) undergoing cervical cerclage. Data from a prospective study were compared with those from a retrospective study. Sixteen ICSI pregnant women, 20 - 24 weeks' gestation and maternal age >18 years, received atosiban (bolus dose 6.75 mg i.v., followed by 300 μg/min i.v. for 3 h and 100 μg/min i.v. for 45 h). Cervical cerclage was performed 3 h after starting atosiban. The control group (group B) of 16 ICSI pregnant women were matched and received ritodrine hydrochloride (100 - 350 μg/min) for 48 h. Cervical cerclage was performed after 24 h. Pre-term rupture of membranes occurred within 48 h of cervical cerclage in one woman receiving atosiban and in four women receiving ritodrine. There was no significant difference in terms of pregnancies not delivered at 48 h (short-term tocolysis) and at 7 days (long-term tocolysis). However, there was a significantly higher incidence of maternal tachycardia with ritodrine compared with atosiban (p
Databáze: OpenAIRE